In this context, we sought to characterize the metabolic reprogramming that takes place during the differentiation/retrodifferentiation of tumour-derived hepatocytes and specify the role of PPARγ in the metabolic adaptation of hepatic CSCs. Here, PPARG is linked to neoplasm.